• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·DLCL.BO
Share

Dr Lalchandani Labs Limited Stocks

₹ 7.49Last Updated 19.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

₹ 318968.76843

₹ 7.49
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Dr. Lalchandani Labs Ltd. specializes in providing diagnostic and allied healthcare services. The company furnishes both individuals and medical practitioners with a wide array of diagnostic tests and services. These offerings are vital for fundamental health screening, patient diagnosis, and the proactive prevention, ongoing monitoring, and effective treatment of illnesses and other medical conditions. Arjan Lal Chandani founded this enterprise in 1986, and its primary operations are based in New Delhi, India.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 01:11

SpaceX's earnings were more than double market expectations

21.10.2026 00:45

The Wells Fargo indicator has issued a buy signal for the first time in nearly 1.5 years

20.10.2026 23:27

AI giants are pushing for data center savings. Who stands to lose?

20.10.2026 22:32

DeepSeek open-sources tool to help cut AI operating costs

20.10.2026 21:47

‘Roller coaster’: What Wall Street expects from SpaceX third-quarter earnings

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026